Theriva Biologics Inc (AMEX:TOVX) currently has a daily average trading volume of 1.92M but it saw 2887277 shares traded in last market. With a market cap of 3.31M USD, the company’s current market price of $1.46 came falling about -1.35 while comparing to the previous closing price of $1.48. In past 52 weeks, the stock remained buoying in the range of price level as high as $17.11 and as low as $1.24. In the recent trading on the day, stock has struck highest price mark of $1.4003 while lowest mark touched by it was $1.52.
Taking a look at 20-day trading activity of Theriva Biologics Inc (TOVX) gives us an average price of $1.5052, while its current price level is -91.47% below from 52-week high level whereas it is 17.74% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $2.5973 while that of 200 days or SMA-200 reads an average of $7.4513. A closer look into the stock’s movement over the week reveals that its volatility is standing at 6.56% during that period while stretching the period over a month that increases to 9.05%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 35.97 which implies that the stock is in neutral territory.
Over the week, TOVX’s stock price is moving -2.67% down while it is 17.74% when we observe its performance for the past one month. Year-to-date it is -86.42% down and over the past year, the stock is showing a downside performance of -86.96%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -8.5 beat the consensus estimate of -9 for the same. The company is expected to be releasing its next quarterly report on 2024-Aug-13, for which analysts forecasted an EPS of 0 while estimate for next year EPS is -26.5.
Currently, Theriva Biologics Inc’s total number of outstanding shares is 2.27M. Company’s return on investment (ROI) stands at -77.05% and return on equity (ROE) at -59.07%. Stock’s beta reads 1.35. Stock has a price to book (P/B) ratio of 0.05. Its return on asset (ROA) is -41.30% on average.
